A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

NCT07766642 | Active Not Recruiting

• 2 other identifiers: 20827legacy-20827
• Study Type: interventional
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

This study will evaluate the effects of the Auri Super Mushroom Daily Gummies For Kids on focus and energy in children aged 4-12. The study is a single-arm, unblinded, virtual trial conducted over 8 weeks, in which all 35 enrolled participants will use the test product daily. Parents of the participants will complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8 to assess perceived changes in their child's focus, attention, sleep quality, gut health, natural energy, and overall well-being. Participants will also undergo cognitive battery testing at Baseline, Week 4, and Week 8 to provide objective measurements of focus and cognitive performance.

Conditions

Difficulty Focusing; Poor Concentration; Poor Memory; Low Energy

Outcome Measures

Primary Outcomes (2)

• Change in Focus

  Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire

  Baseline, Week 4, and Week 8

• Change in Cognitive Performance

  Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire

  Baseline, Week 4, and Week 8

Secondary Outcomes (6)

• Change in Parent-Reported Focus

  Baseline, Week 2, Week 4, Week 6, and Week 8

• Change in Parent-Reported Attention

  Baseline, Week 2, Week 4, Week 6, and Week 8

• Change in Parent-Reported Sleep Quality

  Baseline, Week 2, Week 4, Week 6, and Week 8

• Change in Parent-Reported Gut Health

  Baseline, Week 2, Week 4, Week 6, and Week 8

• Change in Parent-Reported Natural Energy

  Baseline, Week 2, Week 4, Week 6, and Week 8

Study Arms (1)

Auri Super Mushroom Daily Gummies For Kids

EXPERIMENTAL

Dietary Supplement: Auri Super Mushroom Daily Gummies For Kids

Interventions

Auri Super Mushroom Daily Gummies For Kids DIETARY_SUPPLEMENT

All participants receive two Auri Super Mushroom Daily Gummies once daily in the morning with their first meal of the day for 8 weeks.

Auri Super Mushroom Daily Gummies For Kids

Eligibility Criteria

• Age: 4 Years - 12 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Be male or female.
• Be aged 4-12.
• Parent(s) reporting that their child has been experiencing issues regarding any of the following for the past four weeks: Difficulty focusing, Poor concentration, or Poor memory.
• Parent(s) who report that their child will be willing to complete cognitive assessments at regular intervals during the study.
• Any child who is generally healthy - does not live with any uncontrolled chronic disease.
• Parent(s) who are willing to follow the study protocol and support their child to complete all study actions.
• Any child who has no planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
• Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period.
• If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months.
• Has had a stable diet and sleep schedule for at least four weeks prior to the study.
• Enrolled in and currently attending school at baseline and for the duration of the study period.
• Resides in the United States.

You may not qualify if:

• Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
• Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
• Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
• Any child diagnosed with epilepsy or a seizure disorder.
• Any child diagnosed with a bleeding disorder.
• Any child with any known allergies or hypersensitivities to any supplement product ingredients.
• Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period.
• Any parent or child currently testing, or planning on starting in the next eight weeks, a product for another research study.

Sponsors & Collaborators

• Auri Nutrition: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89101, United States

Location

MeSH Terms

Conditions

Memory Disorders

Condition Hierarchy (Ancestors)

Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 11, 2026
• First Posted: August 14, 2026
• Study Start: March 13, 2026
• Primary Completion (Estimated): September 1, 2026
• Study Completion (Estimated): September 1, 2026
• Last Updated: August 14, 2026

Record last verified: 2026-08

Locations

US (1)